Citation Impact
Citing Papers
Management of Stroke in Infants and Children
2008
Involvement of oxygen-sensing pathways in physiologic and pathologic erythropoiesis
2009 StandoutNobel
Endogenous tissue-type plasminogen activator and risk of myocardial infarction
1993
alpha 2-Antiplasmin Enschede: dysfunctional alpha 2-antiplasmin molecule associated with an autosomal recessive hemorrhagic disorder.
1987
Characterization of the Binding of Different Conformational Forms of Plasminogen Activator Inhibitor-1 to Vitronectin
1997
Sepsis biomarkers: a review
2010 Standout
Structural and Functional Analysis of the Plasminogen Activator Inhibitor-1 Binding Motif in the Somatomedin B Domain of Vitronectin
1996
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
2010 Standout
Hypoxia Regulates CD44 and Its Variant Isoforms through HIF-1α in Triple Negative Breast Cancer
2012 StandoutNobel
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
Human Fibrinogen
1988
Glycosylation inhibitors in biology and medicine
1995
Low-Density Lipoprotein Receptor-Related Protein-1 Mediates Endocytic Clearance of Tissue Inhibitor of Metalloproteinases-1 and Promotes Its Cytokine-Like Activities
2014 StandoutNobel
Plasminogen activator inhibitor 1. Structure of the native serpin, comparison to its other conformers and implications for serpin inactivation
2000
Absence of Thrombosis in Subjects with Heterozygous Protein C Deficiency
1987
Hemostatic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients with Angina Pectoris
1995 Standout
Plasminogen Activator Inhibitor-1 and Vitronectin Promote the Cellular Clearance of Thrombin by Low Density Lipoprotein Receptor-related Proteins 1 and 2
1996
Heat Shock Protein A12B Protects Vascular Endothelial Cells Against Sepsis-Induced Acute Lung Injury in Mice
2017 Standout
Engineering Plasminogen Activator Inhibitor 1 Mutants with Increased Functional Stability
1994
Mutation in the Gene Coding for Coagulation Factor V and the Risk of Myocardial Infarction, Stroke, and Venous Thrombosis in Apparently Healthy Men
1995 Standout
Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
1994 Standout
The Fibrinolytic System of the Vessel Wall and Its Role in the Control of Thrombosis
1990
Ganglion-specific splicing of TRPV1 underlies infrared sensation in vampire bats
2011 StandoutNatureNobel
Malaria
2013 Standout
Factors affecting .gamma.-chain multimer formation in crosslinked fibrin
1992
A Serpin Shapes the Extracellular Environment to Prevent Influenza A Virus Maturation
2015 StandoutNobel
Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor.
1993
Regulation of angiogenesis by hypoxia: role of the HIF system
2003 StandoutNobel
Tissue Plasminogen Activator Contributes to the Late Phase of LTP and to Synaptic Growth in the Hippocampal Mossy Fiber Pathway
1998 StandoutNobel
Sepsis and septic shock
2018 Standout
11 The molecular genetics of familial venous thrombosis
1994
FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system
2009
Nonlinear elasticity in biological gels
2005 StandoutNature
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Glioblastoma expression of vitronectin and the alpha v beta 3 integrin. Adhesion mechanism for transformed glial cells.
1991
Engineering Factor Viii for Hemophilia Gene Therapy
2012
Keeping the blood flowing—plasminogen activator genes and feeding behavior in vampire bats
2008
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
2010
Atherosclerosis — An Inflammatory Disease
1999 Standout
Severe Adverse Cutaneous Reactions to Drugs
1994 Standout
Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-alpha, and transforming growth factor-beta.
1991
Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterization.
1993
Sphingosine 1-phosphate receptors in health and disease: Mechanistic insights from gene deletion studies and reverse pharmacology
2007
Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
1991 Standout
Transforming Growth Factor β in Tissue Fibrosis
1994 Standout
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
2001 Standout
World distribution of factor V Leiden
1995 Standout
Disseminated Intravascular Coagulation
1999 Standout
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
1996 StandoutNature
The coagulopathy of acute sepsis
2015
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men
1997 Standout
Cornerstones of CRISPR–Cas in drug discovery and therapy
2016 StandoutNobel
Immunogenicity of protein therapeutics
2007
Biochemical and biological aspects of the plasminogen activation system
1990
Moyamoya Disease and Moyamoya Syndrome
2009 Standout
The pathogenesis of atherosclerosis: a perspective for the 1990s
1993 StandoutNature
Elevated plasma levels of vascular endothelial cell markers in patients with hypercholesterolemia
1993
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
2009 Standout
Etiology of stroke in children
2000
The immunopathogenesis of sepsis
2002 StandoutNature
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro.
1990
LDL receptor-related protein-1 is a sialic-acid-independent receptor for myelin-associated glycoprotein that functions in neurite outgrowth inhibition by MAG and CNS myelin
2012
Serpin Structure, Mechanism, and Function
2002 Standout
CHD4-regulated plasmin activation impacts lymphovenous hemostasis and hepatic vascular integrity
2016
Localization of vitronectin binding domain in plasminogen activator inhibitor-1.
1994
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Cross-linking site in fibrinogen for alpha 2-plasmin inhibitor.
1986
Tissue-type plasminogen activator increases the binding of glu-plasminogen to clots.
1984
Human Plasminogen Activator Inhibitor-1 (PAI-1) Deficiency: Characterization of a Large Kindred With a Null Mutation in the PAI-1 Gene
1997
Pigment Epithelium-Derived Factor: A Potent Inhibitor of Angiogenesis
1999 StandoutScience
Self-Assembled Organic Monolayers: Model Systems for Studying Adsorption of Proteins at Aurfaces
1991 StandoutScience
Investigating Cellular Metabolism of Synthetic Azidosugars with the Staudinger Ligation
2002 StandoutNobel
Thrombin neutralizes plasminogen activator inhibitor 1 (PAI-1) that is complexed with vitronectin in the endothelial cell matrix.
1991
Structure-function studies of the SERPIN plasminogen activator inhibitor type 1. Analysis of chimeric strained loop mutants
1990
Mechanically activated ion channel PIEZO1 is required for lymphatic valve formation
2018 StandoutNobel
Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells
2010 StandoutNobel
Coronary Plaque Disruption
1995 Standout
Plasma Concentration of Interleukin-6 and the Risk of Future Myocardial Infarction Among Apparently Healthy Men
2000 Standout
Induction of the Plasminogen Activator Inhibitor-1 Gene Expression by Mild Hypoxia Via a Hypoxia Response Element Binding the Hypoxia-Inducible Factor-1 in Rat Hepatocytes
1999
Low-affinity heparin stimulates the inactivation of plasminogen activator inhibitor-1 by thrombin
1994
ADAMTS13 Deficiency with Elevated Levels of Ultra-Large and Active von Willebrand Factor in P. falciparum and P. vivax Malaria
2009
NMR Assignment and Secondary Structure Determination of an Octameric 110 kDa Protein Using TROSY in Triple Resonance Experiments
2000 StandoutNobel
On the target specificity of plasminogen activator inhibitor 1: the role of heparin, vitronectin, and the reactive site
1991
Hypoxia Enhances Tumor Stemness by Increasing the Invasive and Tumorigenic Side Population Fraction
2008
Requirement of Vascular Integrin α v β 3 for Angiogenesis
1994 StandoutScience
Albumin modulates lateral assembly of fibrin polymers: evidence of enhanced fine fibril formation and of unique synergism with fibrinogen
1987
Venous thrombosis: a multicausal disease
1999 Standout
Expression, secretion, and age-related downregulation of pigment epithelium-derived factor, a serpin with neurotrophic activity
1995
Alteration of serpin specificity by a protein cofactor. Vitronectin endows plasminogen activator inhibitor 1 with thrombin inhibitory properties.
1990
Fate of fibrinogen in human arterial intima.
1990
Expression of hypoxia-inducible factor 1? in brain tumors
2000 StandoutNobel
Control of Erythropoietin Gene Expression and its Use in Medicine
2007
Metalloproteinase regulation improves in vitro generation of efficacious platelets from mouse embryonic stem cells
2008
Atrial Fibrillation Activates Platelets and Coagulation in a Time-Dependent Manner: A Study in Patients With Paroxysmal Atrial Fibrillation
1997
The role of fragment X polymers in the fibrin enhancement of tissue plasminogen activator-catalyzed plasmin formation.
1990 StandoutNobel
High‐affinity binding sites for human Glu‐plasminogen unveiled by limited plasmic degradation of human fibrin
1986
Extension of Life-Span by Introduction of Telomerase into Normal Human Cells
1998 StandoutScience
Recombinant immunotoxin for cancer treatment with low immunogenicity by identification and silencing of human T-cell epitopes
2014 StandoutNobel
Works of Jun Mimuro being referenced
Plasminogen Activator Inhibitor 1 Promotes a Poor Prognosis in Sepsis-Induced Disseminated Intravascular Coagulation
2006
Induction of immune tolerance by neonatal intravenous injection of human factor VIII in murine hemophilia A
2004
A Thrombotic State Due to an Abnormal Protein C
1988
Effect of glycosidase inhibitors on the biosynthesis of α2-plasmin inhibitor and antithrombin III in Hep G2 cells
1994
Interactions between type 1 plasminogen activator inhibitor, extracellular matrix and vitronectin
1990
Interactions between the Finger and Kringle-2 Domains of Tissue-Type Plasminogen Activator and Plasminogen Activator Inhibitor-11
1992
Retinal pigment epithelial cells produce a latent fibrinolytic inhibitor that is antigenically and biochemically related to type 1 plasminogen activator inhibitor produced by vascular endothelial cells
1989
cDNA for bovine type 1 plasminogen activator Inhibitor (PMI-1)
1989
Liver‐restricted expression of the canine factor VIII gene facilitates prevention of inhibitor formation in factor VIII‐deficient mice
2009
Unbalanced expression of ADAMTS13 and von Willebrand factor in mouse endotoxinemia
2007
Identification of the plasminogen activator inhibitor-1 binding heptapeptide in vitronectin
1993
Adipose Tissue as a Novel Target for In Vivo Gene Transfer by Adeno-Associated Viral Vectors
2006
Purification of a Protein from Bovine Plasma That Binds to Type 1 Plasminogen Activator Inhibitor and Prevents Its Interaction with Extracellular Matrix
1989
Severe secondary deficiency of von Willebrand factor–cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure
2005
Binding of Type 1 Plasminogen Activator Inhibitor to the Extracellular Matrix of Cultured Bovine Endothelial Cells
1989
Type 1 plasminogen activator inhibitor.
1989
Purpura Fulminans in a Chinese Boy With Congenital Protein C Deficiency
1986
Efficient expression of a transgene in platelets using simian immunodeficiency virus‐based vector harboring glycoprotein Ibα promoter: in vivo model for platelet‐targeting gene therapy
2006
Type 1 plasminogen activator inhibitor
1990
Monoclonal antibodies to discrete regions in alpha 2-plasmin inhibitor
1987
Combination of thrombin-antithrombin complex, plasminogen activator inhibitor-1, and protein C activity for early identification of severe coagulopathy in initial phase of sepsis: a prospective observational study
2014
Differential binding of plasminogen to crosslinked and noncrosslinked fibrins: its significance in hemostatic defect in factor XIII deficiency
1984
Essential Roles of Sphingosine 1-Phosphate/S1P1 Receptor Axis in the Migration of Neural Stem Cells Toward a Site of Spinal Cord Injury
2006
Monoclonal antibodies to discrete regions in alpha 2-plasmin inhibitor
1987
PLASMINOGEN ACTIVATOR INHIBITOR
1987
Expression of Plasminogen Activator Inhibitor 2 in the Adult and Embryonic Mouse Tissues
1996
Histidine-rich glycoprotein and α2-plasmin inhibitor in inhibition of plasminogen binding to fibrin
1984
Release of alpha 2-plasmin inhibitor from plasma fibrin clots by activated coagulation factor XIII. Its effect on fibrinolysis.
1986